Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (381-390 of 509) with videos related to

Pageof 51
Sort By:
AIDS (London, England)|June 24, 2003
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD studyNina Friis-Møller, Rainer Weber, Peter Reiss, et al.
Plos One|January 3, 2018
Correction: Long-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-CohortsSophie Cohen, Steve Innes, Sibyl P M Geelen, et al.
Eclinicalmedicine|September 14, 2019
Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort StudyCamilla Ingrid Hatleberg, Lene Ryom, David Kamara, et al.
AIDS (London, England)|October 17, 2018
Do people living with HIV experience greater age advancement than their HIV-negative counterparts?Davide De Francesco, Ferdinand W Wit, Alexander Bürkle, et al.
Journal of Hepatology|April 10, 2019
Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategiesGilles Wandeler, Etienne Mauron, Andrew Atkinson, et al.
BMC Infectious Diseases|October 11, 2013
Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort studySigne W Worm, Mark Bower, Peter Reiss, et al.
AIDS (London, England)|October 26, 2012
An internationally generalizable risk index for mortality after one year of antiretroviral therapyJanet P Tate, Amy C Justice, Michael D Hughes, et al.
International Journal of STD & AIDS|February 6, 2024
COVID-19 epidemiology and performance of the WHO clinical algorithm to diagnose COVID-19 in people with HIV from UkraineMarta Vasylyev, Vira Buhiichyk, Nadiia Buhiichyck, et al.
The Journal of Infectious Diseases|September 11, 2019
Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) StudyLene Ryom, Jens Dilling Lundgren, Peter Reiss, et al.
The Journal of Infectious Diseases|December 29, 2020
Plasma Inflammatory Biomarkers Predict CD4+ T-cell Recovery and Viral Rebound in HIV-1 Infected Africans on Suppressive Antiretroviral TherapyStefanie Kroeze, Theresa M Rossouw, Helen C Steel, et al.
Pageof 51

Showing results (381-390 of 509) with videos related to

Sort By:
Pageof 51
AIDS (London, England)|June 24, 2003
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD studyNina Friis-Møller, Rainer Weber, Peter Reiss, et al.
Plos One|January 3, 2018
Correction: Long-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-CohortsSophie Cohen, Steve Innes, Sibyl P M Geelen, et al.
Eclinicalmedicine|September 14, 2019
Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort StudyCamilla Ingrid Hatleberg, Lene Ryom, David Kamara, et al.
AIDS (London, England)|October 17, 2018
Do people living with HIV experience greater age advancement than their HIV-negative counterparts?Davide De Francesco, Ferdinand W Wit, Alexander Bürkle, et al.
Journal of Hepatology|April 10, 2019
Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategiesGilles Wandeler, Etienne Mauron, Andrew Atkinson, et al.
BMC Infectious Diseases|October 11, 2013
Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort studySigne W Worm, Mark Bower, Peter Reiss, et al.
AIDS (London, England)|October 26, 2012
An internationally generalizable risk index for mortality after one year of antiretroviral therapyJanet P Tate, Amy C Justice, Michael D Hughes, et al.
International Journal of STD & AIDS|February 6, 2024
COVID-19 epidemiology and performance of the WHO clinical algorithm to diagnose COVID-19 in people with HIV from UkraineMarta Vasylyev, Vira Buhiichyk, Nadiia Buhiichyck, et al.
The Journal of Infectious Diseases|September 11, 2019
Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) StudyLene Ryom, Jens Dilling Lundgren, Peter Reiss, et al.
The Journal of Infectious Diseases|December 29, 2020
Plasma Inflammatory Biomarkers Predict CD4+ T-cell Recovery and Viral Rebound in HIV-1 Infected Africans on Suppressive Antiretroviral TherapyStefanie Kroeze, Theresa M Rossouw, Helen C Steel, et al.
Pageof 51